gastrins and Osteoporosis--Postmenopausal

gastrins has been researched along with Osteoporosis--Postmenopausal* in 2 studies

Other Studies

2 other study(ies) available for gastrins and Osteoporosis--Postmenopausal

ArticleYear
Drug-induced prevention of gastrectomy- and ovariectomy-induced osteopaenia in the young female rat.
    The Journal of endocrinology, 2002, Volume: 175, Issue:3

    Both ovariectomy (Ovx) and gastrectomy (Gx) induce osteopaenia in rats and humans. While the effect of Ovx has been ascribed to oestrogen deficiency, the underlying mechanism behind Gx is poorly understood. Alendronate, oestrogen and parathyroid hormone (PTH) are known to prevent the osteopaenia induced by Ovx in rats. The purpose of the present study was to determine whether alendronate, oestrogen or PTH could also prevent Gx-evoked osteopaenia. Rats were Ovx-, Gx-, or were sham-operated (Sham) and were then treated with alendronate (50 micro g/kg/day), oestrogen (10 micro g/kg/day) or PTH(1-84) (75 micro g/kg/day) for eight weeks. At sacrifice, serum PTH was unaffected by surgery (Ovx, 64+/-8 pg/ml; Gx, 75+/-13 pg/ml; Sham, 58+/-11 pg/ml). The bone mineral density (BMD) of the fifth lumbar vertebra (L5) was analysed. Ovx and Gx reduced the BMD (ash weight/Volume) of the L5 by 15+/-4% and 22+/-3% respectively. Trabecular BMD and the cortical bone mineral content (BMC) of the femur were assessed using peripheral computed tomography. Both Ovx and Gx markedly reduced trabecular BMD in the metaphyseal area of the distal femur (Ovx, -37+/-7%; Gx, -49+/-7%). The cortical BMC of the femur was only slightly reduced. Alendronate prevented trabecular bone loss after both Ovx and Gx, while oestrogen and PTH prevented trabecular bone loss after Ovx but not after Gx. In conclusion, the bisphosphonate alendronate prevented both Ovx- and Gx-induced trabecular bone loss. In contrast, PTH and oestrogen prevented Ovx-induced but not Gx-induced trabecular bone loss, suggesting that the mechanism behind the trabecular bone loss in Ovx rats differs from that in Gx rats. The results support the notion that the mechanism of action for the bone-sparing effect of these drugs differs. The ability of alendronate, and probably also other bisphosphonates, to prevent Gx-evoked osteopaenia in the rat might be of potential clinical interest when dealing with post-Gx osteopaenia in humans.

    Topics: Alendronate; Analysis of Variance; Animals; Biomarkers; Bone Density; Bone Diseases, Metabolic; Estradiol; Female; Gastrectomy; Gastrins; Humans; Models, Animal; Osteocalcin; Osteoporosis, Postmenopausal; Ovariectomy; Parathyroid Hormone; Random Allocation; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Tomography, X-Ray Computed

2002
Biochemical and hormonal variables in black and white women matched for age and weight.
    The Journal of laboratory and clinical medicine, 1998, Volume: 132, Issue:5

    Weight and age may influence the levels of indexes of bone remodeling and the calciotropic hormones. In a study of interracial differences in these women, our black population was heavier than our white population. We therefore matched a subset of 96 black and 96 white women from our larger population for age and weight to determine whether a racial difference exists independent of the effects of weight and age. In addition, we were able to measure other indexes of bone remodeling (N-telopeptide of cross-linked collagen and pyridinoline cross-links), as well as hormones that may influence calcium metabolism (insulin-like growth factor-1 (IGF-1), insulin, calcitonin, and gastrin) in this subset. All indexes of bone remodeling were lower in black women. Black postmenopausal women had lower serum levels of calcidiol and higher parathyroid hormone (PTH) levels. The higher bone mass of black women is associated with lower bone remodeling in the presence of skeletal resistance to PTH. Serum IGF- 1, insulin, and calcitonin levels did not differ significantly between races. Serum gastrin levels were higher in black women. The higher levels of gastrin in black women should be investigated further for its possible effect on the absorption of calcium salts.

    Topics: Adult; Black People; Body Mass Index; Bone Density; Bone Remodeling; Calcifediol; Calcitonin; Calcium; Collagen; Collagen Type I; Female; Gastrins; Hormones; Humans; Insulin; Insulin-Like Growth Factor I; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Peptides; White People

1998